The study and its comparison
The randomized research included 736 participants. Its population was pregnant women enrolled at twenty-four weeks; 695 children included. The comparison used long-chain omega-3 fatty acids 2.4 g daily versus olive-oil placebo, with observation over childhood follow-up, double-blind for the first three years. [1]
Persistent wheeze or asthma occurred in 16.9% of the intervention group versus 23.7% of controls. Eczema, allergic sensitization and asthma exacerbations did not show significant differences. Lower starting maternal omega-3 levels identified a stronger subgroup signal. [1]
What the finding establishes
The primary combined endpoint is not identical to every later asthma diagnosis. Subgroup findings need caution and do not define a universal prenatal dose. The Lundbeck Foundation and others funded the research; complete conflicts were not established from the abstract. [1]
A hypothetical distinction
Imagine risk falls from 23.7% to 16.9%. The absolute decrease is 6.8 percentage points, while the relative decrease uses a different denominator.
| Detail | Interpretation |
|---|---|
| Measured outcome | Keep the endpoint specific |
| Study preparation | Not every retail product |
| Remaining uncertainty | Not resolved by a mechanism |
Sources for this article
- Fish Oil-Derived Fatty Acids in Pregnancy and Wheeze and Asthma in Offspring.
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.